Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice [0.03%]
稳定型心绞痛的新固定剂量伊伐布雷定和美托洛尔联合治疗：常规临床实践中的有效性和耐受性
Dimitar Divchev,Georg Stöckl;study investigators
Dimitar Divchev
Introduction: In this prospective, multicenter, observational cohort study, the effectiveness and tolerability of the first fixed-dose combination (FDC) formulation of the selective heart rate reducing agent ivabradine an...
From CoreValve to Evolut PRO: Reviewing the Journey of Self-Expanding Transcatheter Aortic Valves [0.03%]
从CoreValve到Evolut PRO：自扩张经导管主动脉瓣的发展历程评述
Dhruv Mahtta,Islam Y Elgendy,Anthony A Bavry
Dhruv Mahtta
Transcatheter aortic valve replacement (TAVR) has become standard therapy for patients with severe aortic stenosis who are deemed at least intermediate risk for surgical valve replacement. Over the past decade, several technological advance...
Peter McKavanagh,Bobby Yanagawa,George Zawadowski et al.
Peter McKavanagh et al.
Coronary artery bypass grafting (CABG) remains a vital treatment for patients with multivessel coronary artery disease (CAD), especially diabetics. The long-term benefit of the internal thoracic artery graft is well established and remains ...
Matthias Merkel,Philipp Grotherr,Andrea Radzewitz et al.
Matthias Merkel et al.
Leadless pacing is now an established alternative to conventional pacing with subcutaneous pocket and transvenous lead for patients with class I or II single-chamber pacing indication. Available 12-month follow-up data shows a 48% fewer maj...
Aamir Hameed,Haroon Zafar,Darren Mylotte et al.
Aamir Hameed et al.
Stroke is the second leading cause of death worldwide and in Europe. Even with gold standard medical management of acute ischemic stroke, which is intravenous (IV) thrombolysis by administration of recombinant tissue plasminogen activator (...
Heart Disease and Pregnancy [0.03%]
心脏病与怀孕
Reza Ashrafi,Stephanie L Curtis
Reza Ashrafi
Cardiac disease remains a major cause of morbidity and mortality in pregnant and post-partum women, although progress has been made, with specialist joint obstetric-cardiology clinics providing an integrated, safe and personalised service t...
Comparison of Different Invasive Hemodynamic Measurements as a Prediction Tool for Mortality after Transcatheter Aortic Valve Replacement in Men: A Retrospective Observational Study [0.03%]
经导管主动脉瓣植入术后男性患者不同侵入性血流动力学测量预测死亡率的比较：一项回顾性观察研究
Anthony A Bavry,Seyed H Aalaei-Andabili,Ashkan Karimi et al.
Anthony A Bavry et al.
Introduction: Hemodynamic measurements can assess for paravalvular aortic regurgitation after transcatheter aortic valve replacement (TAVR). This study compared the utility of different invasive hemodynamic measures in pr...
Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients [0.03%]
循环PCSK9浓度升高可预测低危肥胖和非肥胖患者的亚临床动脉粥样硬化变化
Štefan Tóth,Ján Fedačko,Tímea Pekárová et al.
Štefan Tóth et al.
Introduction: Many studies have highlighted the important role of PCSK9 in the development of cardiometabolic changes and its possible function as a biomarker of myocardial infarction or ischemic heart disease. This study...
Medical Therapy and Recurrent Ischemic Events in High Risk Patients Surviving their Myocardial Infarction for at Least 12 Months: Comparison of Patients with ST Elevation Versus Non-ST Elevation Myocardial Infarction [0.03%]
从急性心肌梗死后存活至少一年的高危患者中比较ST段抬高与非ST段抬高型心肌梗死患者的复发缺血事件和药物治疗状况
Uwe Zeymer,Katrin Riedel,Michael Hahn
Uwe Zeymer
Introduction: Data about treatments and recurrent ischemic events in patients surviving their most recent myocardial infarction event-free for at least 12 months are scarce. ...
Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study [0.03%]
抗凝患者的分析管理可能对临床结果产生重大影响：一项随访研究
Vincenzo De Iuliis,Sebastiano Ursi,Gianfranco Vitullo et al.
Vincenzo De Iuliis et al.
Introduction: Oral anticoagulant therapy, such as vitamin K antagonists (VKAs), is prominent for the prevention of cerebral ischemic stroke or systemic embolism and all-cause mortality in patients with atrial fibrillation...